Rotavirus 2/6 virus-like particles administered intranasally in mice, with or without the mucosal adjuvants cholera toxin and Escherichia coli heat-labile toxin, induce a Th1/Th2-like immune response

被引:58
作者
Fromantin, C
Jamot, B
Cohen, J
Piroth, L
Pothier, P
Kohli, E
机构
[1] Univ Bourgogne, Fac Med, Lab Microbiol Med & Mol, F-21033 Dijon, France
[2] Univ Bourgogne, Fac Pharm, Lab Microbiol Med & Mol, F-21033 Dijon, France
[3] INRA, Unite Virol & Immunol Mol, F-78352 Jouy En Josas, France
关键词
D O I
10.1128/JVI.75.22.11010-11016.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 [微生物学]; 100705 [微生物与生化药学];
摘要
We investigated the rotavirus-specific lymphocyte responses induced by intranasal immunization of adult BALB/c mice with rotavirus 2/6 virus-like particles (2/6-VLPs) of the bovine RF strain, by assessing the profile of cytokines produced after in vitro restimulation and serum and fecal antibody responses. The cytokines produced by splenic cells were first evaluated. Intranasal immunization with 50 mug of 2/6-VLPs induced a high serum antibody response, including immunoglobulin G1 (IgG1) and IgG2a, a weak fecal antibody response, and a mixed Th1/Th2-like profile of cytokines characterized by gamma interferon and interleukin 10 (IL-10) production and very low levels of IL-2, IL-4, and IL-5. Intranasal immunization with 10 mug of 2/6-VLPs coadministered with the mucosal adjuvants cholera toxin and Escherichia coli heat-labile toxin (LT) considerably enhanced the Th1/Th2-like response; notably, significant levels of IL-2, IL-4, and IL-5 were observed. Since rotavirus is an enteric pathogen, we next investigated the production of IL-2 and IL-5, as being representative of Th1 and Th2 responses, by Peyer's patch and mesenteric lymph node cells from mice immunized intranasally with 2/6-VLPs and LT. The results were compared to those obtained from splenic and cervical lymph node cells. We found that both cytokines were produced by cells from each of these lymphoid tissues. These results confirm the Th1/Th2-like response observed at the systemic level and show, on the assumption that T cells are the primary cells producing the cytokines after in vitro restimulation, that rotavirus-specific T lymphocytes are present in the intestine after intranasal immunization with 2/6-VLPs and LT.
引用
收藏
页码:11010 / 11016
页数:7
相关论文
共 28 条
[1]
Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity [J].
Ciarlet, M ;
Crawford, SE ;
Barone, C ;
Bertolotti-Ciarlet, A ;
Ramig, RF ;
Estes, MK ;
Conner, ME .
JOURNAL OF VIROLOGY, 1998, 72 (11) :9233-9246
[2]
Nasal immunization of mice with virus-like particles protects offspring against rotavirus diarrhea [J].
Coste, A ;
Sirard, JC ;
Johansen, K ;
Cohen, J ;
Kraehenbuhl, JP .
JOURNAL OF VIROLOGY, 2000, 74 (19) :8966-8971
[3]
CHARACTERIZATION OF VIRUS-LIKE PARTICLES PRODUCED BY THE EXPRESSION OF ROTAVIRUS CAPSID PROTEINS IN INSECT CELLS [J].
CRAWFORD, SE ;
LABBE, M ;
COHEN, J ;
BURROUGHS, MH ;
ZHOU, YJ ;
ESTES, MK .
JOURNAL OF VIROLOGY, 1994, 68 (09) :5945-5952
[4]
Passive immunity to bovine rotavirus in newborn calves fed colostrum supplements from cows immunized with recombinant SA11 rotavirus core-like particle (CLP) or virus-like particle (VLP) vaccines [J].
Fernandez, FM ;
Conner, ME ;
Hodgins, DC ;
Parwani, AV ;
Nielsen, PR ;
Crawford, SE ;
Estes, MK ;
Saif, LJ .
VACCINE, 1998, 16 (05) :507-516
[5]
Oral delivery of homologous and heterologous strains of rotavirus to BALB/c mice induces the same profile of cytokine production by spleen cells [J].
Fromantin, C ;
Piroth, L ;
Petitpas, I ;
Pothier, P ;
Kohli, E .
VIROLOGY, 1998, 244 (02) :252-260
[6]
Imaoka K, 1998, J IMMUNOL, V161, P5952
[7]
Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles [J].
Jiang, BM ;
Estes, MK ;
Barone, C ;
Barniak, V ;
O'Neal, CM ;
Ottaiano, A ;
Madore, HP ;
Conner, ME .
VACCINE, 1999, 17 (7-8) :1005-1013
[8]
KAPIKIAN AZ, 1996, FIELDS VIROLOGY, V2, P1657
[9]
LABBE M, 1991, J VIROL, V65, P2946
[10]
Rotavirus vaccines [J].
Lynch, M ;
Bresee, JS ;
Gentsch, JR ;
Glass, RI .
CURRENT OPINION IN INFECTIOUS DISEASES, 2000, 13 (05) :495-502